FDA Approves Caris Life Sciences CDx for Targeted Cancer Therapy Precision
Caris Life Sciences’ MI Cancer Seek CDx assay received FDA approval to help identify cancer patients who may benefit from targeted therapies.
Read MorePosted by Andy Lundin | Nov 7, 2024 | Cancer |
Caris Life Sciences’ MI Cancer Seek CDx assay received FDA approval to help identify cancer patients who may benefit from targeted therapies.
Read MorePosted by Chris Wolski | Oct 31, 2024 | Cancer |
Scientists at deCODE genetics/Amgen and their collaborators have identified six new genes with rare germline variants linked to cancer risk.
Read MorePosted by Andy Lundin | Oct 24, 2024 | Cancer |
GRAIL’s REFLECTION study on the Galleri multi-cancer early detection test shows promising early results in U.S. veterans.
Read MorePosted by Andy Lundin | Oct 18, 2024 | Cancer |
Researchers are creating a paper-based test that detects cancer’s spread to the central nervous system in the cerebrospinal fluid.
Read MorePosted by Andy Lundin | Oct 17, 2024 | Cancer |
The AI-powered sensor amplifies optical signals in body fluids, enabling non-invasive and rapid cancer diagnosis.
Read More